Full Text (PDF)
Original Article

Medical Management of Diabetic Peripheral Neuropathic Pain: A Focused Review of Literature

P.Senthil Kumar , P.Senthil Kumar , Prabha Adhikari P.S. Jeganathan , Sydney C. D\'souza

Author Information

Licence:




International Journal of Neurology and Neurosurgery 2(1):p 29-46, January - March 2010. | DOI:

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Diabetes is a global epidemic and one of the most leading complications of diabetes is peripheral europathy. Recent research and clinical practice focus is on symptomatic or painful diabetic peripheral neuropathy (PDPN). The objective of this review is to throw light on commonly used and well-established drugs and pharmacotherapy options in PDPN patients. The various drugs reported in controlled clinical trials in MEDLINE were searched independently and 118 suitable trials were identified. The selected studies are grouped under each drug and the drugs are described in alphabetical order in the review. The pharmacotherapy for PDPN patients includes Duloxetine (24 studies), Pregabalin (10 studies), capsaicin 6 studies), Oxcarbazepine (6 studies) and so on. The total number of drugs reviewed under pharmacotherapy for PDPN was 44. The review would facilitate clinicians and stakeholders to understand the established drug therapy options for symptomatic management of patients with painful diabetic peripheral neuropathy, and also facilitate researchers to develop better drugs in future.   

Key words: drug therapy, diabetic neuropathy, neuropathic pain, management. 


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI:

Keywords


Article Level Metrics

Last Updated

Thursday 30 July 2026, 12:33:26 (IST)


1467

Accesses

5
244
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share